Archives

Use the basic search or click on advanced for more search options.

Advanced Search Basic Search Advanced Search

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-10-21
    E.g., 2018-10-21

Archive Search

Pages

116 items
1:34 PM, Apr 27, 2018  |  BC Week In Review | Financial News  |  Withdrawn Offerings

Mereo postpones NASDAQ listing

Mereo BioPharma Group plc (LSE:MPH) said on April 26 it postponed an offering to list its ADSs on NASDAQ and withdrew a concurrent placing, citing market conditions. According to an April 9 SEC filing, the company...
9:55 AM, Mar 23, 2018  |  BC Week In Review | Financial News  |  Withdrawn Offerings

Proteostasis withdraws offering after short report

Respiratory company Proteostasis Therapeutics Inc. (NASDAQ:PTI) withdrew its proposed follow-on late on March 20, citing market conditions. Proteostasis had proposed March 19 after market hours to sell 9 million shares. The company lost $1.83 (26%) to...
1:09 PM, Jan 05, 2018  |  BC Week In Review | Financial News  |  Withdrawn Offerings

Sun BioPharma withdraws follow-on

Cancer company Sun BioPharma Inc. (OTCQB:SNBPD) withdrew its follow-on on Dec. 28, 2017, citing market conditions. On Dec. 18, the company proposed to raise up to $11.5 million in the follow-on underwritten by Aegis Capital...
1:03 PM, May 05, 2017  |  BC Week In Review | Financial News  |  Withdrawn Offerings

BioLight withdraws follow-on

On May 4, ophthalmology company BioLight Life Sciences Ltd. (Tel Aviv:BOLT) withdrew a follow-on seeking to list its shares on NASDAQ in a U.S. IPO underwritten by H.C. Wainwright and Feltl. In February 2016, the...
4:12 PM, Apr 13, 2017  |  BC Week In Review | Financial News  |  Withdrawn Offerings

BioBlast Pharma withdraws follow-on

Rare disease play BioBlast Pharma Ltd. (NASDAQ:ORPN) withdrew its follow-on underwritten by H.C. Wainwright on April 6, citing market conditions. In February, the company proposed to raise up to $11.5 million. BioBlast Pharma Ltd. (NASDAQ:ORPN), Tel...
1:54 PM, Mar 23, 2017  |  BC Week In Review | Financial News  |  Withdrawn Offerings

Provectus withdraws rights offering

On March 20, cancer and dermatology company Provectus Biopharmaceuticals Inc. (OTCQB:PVCT) withdrew its rights offering. Provectus Biopharmaceuticals Inc. (OTCQB:PVCT), Knoxville, Tenn.  ...
8:46 AM, Feb 17, 2017  |  BC Week In Review | Financial News  |  Withdrawn Offerings

Visterra withdraws IPO

On Feb. 10, anti-infectives company Visterra Inc. (Cambridge, Mass.) withdrew its proposed IPO on NASDAQ, citing market conditions. Leerink Partners, Stifel, Needham and Wedbush PacGrow were underwriters. Visterra Inc., Cambridge, Mass.  ...
12:42 PM, Feb 03, 2017  |  BC Week In Review | Financial News  |  Withdrawn Offerings

Braeburn withdraws IPO

On Feb. 2, neurology company Braeburn Pharmaceuticals Inc. (Princeton, N.J.) said it will withdraw its IPO on NASDAQ, citing “significant available capital” and market conditions. Braeburn Pharmaceuticals Inc., Princeton, N.J.  ...
8:28 PM, Jan 26, 2017  |  BC Week In Review | Financial News  |  Withdrawn Offerings

Great Basin Scientific withdraws follow-on

On Jan. 20, molecular diagnostic company Great Basin Scientific Inc. (OTCQB:GBSN) withdrew its follow-on underwritten by Roth Capital Partners. The company said that additional funding was “no longer necessary.” Last August, the company filed to...
12:39 PM, Jan 06, 2017  |  BC Week In Review | Financial News  |  Withdrawn Offerings

Acelity withdraws IPO

Acelity withdrew its IPO on NYSE, citing market conditions. Acelity filed for an IPO in August 2015. Acelity Holdings Inc., San Antonio, Texas  ...

Pages